COAG analyst estimates
Hemab (COAG) analyst ratings, the average price target and its range, and every firm's latest call.
- 3 firms rate COAG: 3 buy, 0 hold, 0 sell.
- The average price target is $51.40 from None analysts, from $36.00 to $64.00.
Updated 2026-11-11 00:48 UTC